1 May 2024

Pain Pharmaceuticals

Under half of fibromyalgia patients use evidence-based drugs

1 May 2024

Pharmaceuticals Public Health

Fresh call to up-schedule modified-release paracetamol

1 May 2024

Atopic Dermatitis Pharmaceuticals Psoriasis

PBAC tick for new psoriasis, HS and AD options

17 April 2024

Acne Pharmaceuticals

Derms prescribe the most antibiotics: US study

17 April 2024

Allergies Pharmaceuticals

Day-to-day protection against food allergy on the horizon

20 March 2024

Hidradenitis Suppurativa Pharmaceuticals

New BTK inhibitor shows promise in hidradenitis suppurativa

6 March 2024

Pharmaceuticals

Oral morphine substitute approved

6 March 2024

Pharmaceuticals Urticaria

Can a new JAK inhibitor help urticaria?

7 February 2024

Neurology Pain Pharmaceuticals TGA Women

Watch for gabapentin skin reactions: TGA

29 November 2023

COVID-19 Pharmaceuticals

Covid curbed antimicrobial use, but for how long?

15 November 2023

Pharmaceuticals psoriatic arthritis

Anti-JAKs safe in skin conditions

2 November 2023

Paediatrics PBS Pharmaceuticals

PBS cuts etanercept red tape

18 October 2023

Pharmaceuticals

Warning over illegal online Mounjaro pedlars

4 October 2023

Pharmaceuticals Psoriasis

Two new plaque psoriasis treatments join PBS

20 September 2023

Bullous Pemphigoid Pharmaceuticals

Dupilumab’s promise in bullous pemphigoid

20 September 2023

Pharmaceuticals

10 Aussie medical milestones, and why they matter